Remicade is an anti-inflammatory medicine. It is usually used when other medicines or treatments have failed, in adults with the following diseases:
• rheumatoid arthritis (an immune system disease causing inflammation of the joints). Remicade is used with methotrexate (a medicine that acts on the immune system);
• Crohn's disease (a disease causing inflammation of the digestive tract), when the disease is moderate to severe or fistulising (with the formation of fistulae ahnormal
passage
Back to top
and other
• ulcerative colitis (a disease raucina inflammation and
=
ema.europa.euC
•••
ylosing spondylitis
Clarice Burke
March 23
What is Remicade supposed to do for you?
Remicade (infliximab) is a biologic DMARD designed to help manage your rheumatoid arthritis by targeting inflammation at its source. Here's what it's supposed to do:
How it works
Remicade blocks a protein called tumor necrosis factor alpha (TNFA), which causes inflammation and Show Full Answer
What is Remicade supposed to do for you?
Remicade (infliximab) is a biologic DMARD designed to help manage your rheumatoid arthritis by targeting inflammation at its source. Here's what it's supposed to do:
How it works:
Remicade blocks a protein called tumor necrosis factor alpha (TNFA), which causes inflammation and bone erosion in RA. By binding to TNFA, it prevents this protein from triggering the immune cells that cause joint inflammation.
What you can expect:
* Reduces joint inflammation and swelling
* Slows down joint damage and disease progression
* May improve your overall symptoms and quality of life
* Helps prevent long-term disability
Treatment details:
Remicade is given through IV infusion, typically taking 2-4 hours per session. You'll usually start with doses every 15 days, then move to maintenance infusions every 8 weeks. It's often combined with methotrexate for better results.
Like other DMARDs, Remicade doesn't just mask symptoms—it actually modifies your immune system to treat the underlying cause of your RA, which can help reduce the risk of complications like heart and lung disease.
March 23